US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 0.640
  • -0.239-27.20%
Close Jul 3 13:00 ET
  • 0.818
  • +0.178+27.78%
Post 16:38 ET
47.26MMarket Cap-7806P/E (TTM)

Conduit Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
95.05%2.96M
66.52%5.26M
-46.54%895K
14.58%1.07M
420.62%1.52M
-0.41%3.16M
1.67M
933K
291K
3.17M
Selling and administrative expenses
86.60%2.83M
69.63%5.17M
-53.22%805K
37.94%1.07M
420.62%1.52M
5.50%3.05M
--1.72M
--775K
--291K
--2.89M
-General and administrative expense
86.60%2.83M
69.63%5.17M
-53.22%805K
37.94%1.07M
420.62%1.52M
5.50%3.05M
--1.72M
--775K
--291K
--2.89M
Research and development costs
--128K
-18.92%90K
291.49%90K
--0
--0
-60.78%111K
---47K
--158K
----
--283K
Operating profit
-95.05%-2.96M
-66.52%-5.26M
46.54%-895K
-14.58%-1.07M
-420.62%-1.52M
0.41%-3.16M
-1.67M
-933K
-291K
-3.17M
Net non-operating interest income expense
-110K
-392K
-300K
-47K
0
0
0
0
0
Non-operating interest income
--9K
--30K
----
----
--0
--0
----
----
----
----
Non-operating interest expense
--119K
--422K
--330K
--47K
--0
--0
--0
--0
--0
----
Other net income (expense)
-210.19%-487K
396.41%5.12M
312.88%2.97M
13,586.96%3.1M
-881.25%-157K
-256.82%-1.73M
-1.4M
-23K
-16K
-484K
Gain on sale of security
----
458.00%5.23M
----
----
----
-255.72%-1.46M
----
----
---15K
---411K
Other non- operating income (expenses)
-210.19%-487K
56.60%-115K
-3,576.92%-2.26M
13,586.96%3.1M
-15,600.00%-157K
-263.01%-265K
--65K
---23K
---1K
---73K
Income before tax
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
-307K
-3.66M
Income tax
Net income
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
-307K
-3.66M
Net income continuous Operations
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-444.63%-1.67M
-33.63%-4.89M
---3.07M
---956K
---307K
---3.66M
Minority interest income
Net income attributable to the parent company
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
-307K
-3.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-112.44%-3.55M
89.05%-535K
157.93%1.78M
307.74%1.99M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
-956K
-307K
-3.66M
Basic earnings per share
-116.56%-0.05
85.18%-0.01
170.74%0.03
327.26%0.03
-444.66%-0.0231
-33.63%-0.0675
-0.0424
-0.0132
-0.0042
-0.0505
Diluted earnings per share
-116.56%-0.05
-33.37%-0.09
52.84%-0.02
327.26%0.03
-444.66%-0.0231
-33.63%-0.0675
-0.0424
-0.0132
-0.0042
-0.0505
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 95.05%2.96M66.52%5.26M-46.54%895K14.58%1.07M420.62%1.52M-0.41%3.16M1.67M933K291K3.17M
Selling and administrative expenses 86.60%2.83M69.63%5.17M-53.22%805K37.94%1.07M420.62%1.52M5.50%3.05M--1.72M--775K--291K--2.89M
-General and administrative expense 86.60%2.83M69.63%5.17M-53.22%805K37.94%1.07M420.62%1.52M5.50%3.05M--1.72M--775K--291K--2.89M
Research and development costs --128K-18.92%90K291.49%90K--0--0-60.78%111K---47K--158K------283K
Operating profit -95.05%-2.96M-66.52%-5.26M46.54%-895K-14.58%-1.07M-420.62%-1.52M0.41%-3.16M-1.67M-933K-291K-3.17M
Net non-operating interest income expense -110K-392K-300K-47K00000
Non-operating interest income --9K--30K----------0--0----------------
Non-operating interest expense --119K--422K--330K--47K--0--0--0--0--0----
Other net income (expense) -210.19%-487K396.41%5.12M312.88%2.97M13,586.96%3.1M-881.25%-157K-256.82%-1.73M-1.4M-23K-16K-484K
Gain on sale of security ----458.00%5.23M-------------255.72%-1.46M-----------15K---411K
Other non- operating income (expenses) -210.19%-487K56.60%-115K-3,576.92%-2.26M13,586.96%3.1M-15,600.00%-157K-263.01%-265K--65K---23K---1K---73K
Income before tax -112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-444.63%-1.67M-33.63%-4.89M-3.07M-956K-307K-3.66M
Income tax
Net income -112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-444.63%-1.67M-33.63%-4.89M-3.07M-956K-307K-3.66M
Net income continuous Operations -112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-444.63%-1.67M-33.63%-4.89M---3.07M---956K---307K---3.66M
Minority interest income
Net income attributable to the parent company -112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-444.63%-1.67M-33.63%-4.89M-3.07M-956K-307K-3.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -112.44%-3.55M89.05%-535K157.93%1.78M307.74%1.99M-444.63%-1.67M-33.63%-4.89M-3.07M-956K-307K-3.66M
Basic earnings per share -116.56%-0.0585.18%-0.01170.74%0.03327.26%0.03-444.66%-0.0231-33.63%-0.0675-0.0424-0.0132-0.0042-0.0505
Diluted earnings per share -116.56%-0.05-33.37%-0.0952.84%-0.02327.26%0.03-444.66%-0.0231-33.63%-0.0675-0.0424-0.0132-0.0042-0.0505
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg